AWMSG medicines approvals
The following medicines have been approved for use in NHS Wales by the All Wales Medicines Strategy Group (AWMSG): Darunavir, in combination with other antiretrovirals, for treating human immunodeficiency virus-1 infection in children aged at least three years and weighing 15kg and over; peginterferon beta-1a for treating adults with relapsing-remitting multiple sclerosis; regorafenib for treating adults with unresectable or metastatic gastrointestinal stromal tumours who progressed on, or are intolerant to, prior treatment with imatinib or sunitinib — provided the approved patient access scheme is used; avanafil for treating erectile dysfunction in adult men and levonorgestrel (Jaydess) as a female contraceptive. The AWMSG website has full details of the restrictions.
Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2015.20069028
Recommended from Pharmaceutical Press